MDoutlook is a leading precision intelligence company.
We build the success of your organization through better decision-making.


Specializing in oncology, hematology, and rare diseases, we answer your business questions with timely precision intelligence using custom marketing research instruments, secondary data sources, our proprietary access to communities [clinicians, ThoughtLeaders and other stakeholders] and our seasoned in-house expertise from across the industry.

Driven by staff medical experts and supported by business consultants, our team engages with ThoughtLeaders and the right clinicians to deliver real-world, actionable insights.


Our solutions
MDoutlook provides agile research-based consulting, custom and syndicated market research,  secondary data analysis & intelligence, ThoughtLeader identification and network mapping, and guaranteed physician engagement.


Click on the icons above to explore how our clients derive value.

What's New at MDoutlook

Oncologists’ Treatment Rationale and Wish-List in IO

21 May 2020

The latest release from our annual corporate leadership reveals multiple factors supporting the use of an IO approach having similar impact on treatment decisions. Factors…


Mastering Virtual Conference Data Presentation Impact

07 May 2020

With ASCO announcing their inaugural virtual program last week and ahead of other major oncology and hematology conferences (such as EHA) moving online, client appetite…


Leadership Success in IO from Oncologists’ Perspectives

22 Apr 2020

Having recently named the 2020 leaders in oncology and ImmunoOncology, our latest release from our annual Corporate Leadership report reveals the key attributes oncologists view…


What's Trending in Oncology (updated hourly)